These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 33842675)
21. Natural compounds from Kar P; Sharma NR; Singh B; Sen A; Roy A J Biomol Struct Dyn; 2021 Aug; 39(13):4774-4785. PubMed ID: 32552595 [TBL] [Abstract][Full Text] [Related]
22. Anti-COVID-19 activity of some benzofused 1,2,3-triazolesulfonamide hybrids using Alzahrani AY; Shaaban MM; Elwakil BH; Hamed MT; Rezki N; Aouad MR; Zakaria MA; Hagar M Chemometr Intell Lab Syst; 2021 Oct; 217():104421. PubMed ID: 34538993 [TBL] [Abstract][Full Text] [Related]
23. Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells. Vardhan S; Sahoo SK J Tradit Complement Med; 2022 Jan; 12(1):6-15. PubMed ID: 33868970 [TBL] [Abstract][Full Text] [Related]
28. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an Pandey P; Rane JS; Chatterjee A; Kumar A; Khan R; Prakash A; Ray S J Biomol Struct Dyn; 2021 Oct; 39(16):6306-6316. PubMed ID: 32698689 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of bioactive compounds from Roy A; Menon T Vegetos; 2022; 35(2):404-414. PubMed ID: 34803247 [TBL] [Abstract][Full Text] [Related]
30. Potential inhibitors of SARS-CoV-2 (COVID 19) spike protein of the delta and delta plus variant: In silico studies of medicinal plants of North-East India. Solo P; Doss MA Curr Res Pharmacol Drug Discov; 2021; 2():100065. PubMed ID: 34870160 [TBL] [Abstract][Full Text] [Related]
31. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19. Balkrishna A; Mittal R; Arya V Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach. Zapata-Cardona MI; Florez-Alvarez L; Guerra-Sandoval AL; Chvatal-Medina M; Guerra-Almonacid CM; Hincapie-Garcia J; Hernandez JC; Rugeles MT; Zapata-Builes W AIMS Microbiol; 2023; 9(1):20-40. PubMed ID: 36891537 [TBL] [Abstract][Full Text] [Related]
33. Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Mir SA; Firoz A; Alaidarous M; Alshehri B; Bin Dukhyil AA; Banawas S; Alsagaby SA; Alturaiki W; Bhat GA; Kashoo F; Abdel-Hadi AM Saudi J Biol Sci; 2022 Jan; 29(1):394-401. PubMed ID: 34518755 [TBL] [Abstract][Full Text] [Related]
34. Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19. Rabie AM Curr Res Pharmacol Drug Discov; 2021; 2():100055. PubMed ID: 34870153 [TBL] [Abstract][Full Text] [Related]
35. Molecular docking and dynamics studies of Nicotinamide Riboside as a potential multi-target nutraceutical against SARS-CoV-2 entry, replication, and transcription: A new insight. Esam Z; Akhavan M; Lotfi M; Bekhradnia A J Mol Struct; 2022 Jan; 1247():131394. PubMed ID: 34483364 [TBL] [Abstract][Full Text] [Related]
36. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2. Drak Alsibai K Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290 [TBL] [Abstract][Full Text] [Related]
37. In silico screening, ADMET analysis and MD simulations of phytochemicals of Vegad UG; Gajjar ND; Nagar PR; Chauhan SP; Pandya DJ; Dhameliya TM 3 Biotech; 2023 Jul; 13(7):221. PubMed ID: 37265541 [TBL] [Abstract][Full Text] [Related]
38. Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection. Goyal RK; Majeed J; Tonk R; Dhobi M; Patel B; Sharma K; Apparsundaram S Rev Cardiovasc Med; 2020 Sep; 21(3):365-384. PubMed ID: 33070542 [TBL] [Abstract][Full Text] [Related]
39. Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an Das BS; Das NC; Swain SS; Mukherjee S; Bhattacharya D Future Virol; 2022 Jun; ():. PubMed ID: 35812188 [No Abstract] [Full Text] [Related]
40. Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation. Aouidate A; Ghaleb A; Chtita S; Aarjane M; Ousaa A; Maghat H; Sbai A; Choukrad M; Bouachrine M; Lakhlifi T J Biomol Struct Dyn; 2021 Aug; 39(12):4522-4535. PubMed ID: 32552534 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]